Recurrent Gallbladder Cancer
Current Clinical Trials
The prognosis for any treated cancer patient with progressing or recurrent
gallbladder cancer is poor. The question and selection of further treatment
depends on many factors: tumor burden, prior treatment, site of recurrence,
and individual patient considerations. Patients may have portal hypertension
caused by portal vein compression by the tumor. Transperitoneal and
intrahepatic metastases are not uncommon. Clinical trials are appropriate and
should be considered when possible.
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent gallbladder cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
Back to Top
< Previous Section | Next Section > |